The Indian pharmaceuticals sector is poised for robust revenue growth of 8-10% this fiscal year, building on last year's approximately 10% increase. This growth is attributed to strong exports to regulated markets, a rebound in semi-regulated markets, and consistent domestic demand.Improved Operating Margins As a result